Zymeworks Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating includes seventeen United Nations SDGs including: 'Gender Equality', 'Climate Action' and 'Partnerships for the Goals'. The webpage of Zymeworks Inc is prepared by All Street Sevva using cutting edge machine learning. Other corporations in the scoring industry group for Zymeworks Inc are shown.
Zymeworks Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.0, social score of 4.8 and governance score of 4.8.
3.9
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
1004 | Xeris Pharmaceuticals Inc | 4.0 | High |
1004 | Xenon Pharmaceuticals Inc | 4.0 | High |
... | ... | ... | |
1089 | Zymeworks Inc | 3.9 | Medium |
1089 | Aclaris Therapeutics Inc | 3.9 | Medium |
1089 | Allogene Therapeutics Inc | 3.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Zymeworks Inc have an accelerator or VC vehicle to help deliver innovation?
Does Zymeworks Inc disclose current and historical energy intensity?
Does Zymeworks Inc report the average age of the workforce?
Does Zymeworks Inc reference operational or capital allocation in relation to climate change?
Does Zymeworks Inc disclose its ethnicity pay gap?
Does Zymeworks Inc disclose cybersecurity risks?
Does Zymeworks Inc offer flexible work?
Does Zymeworks Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Zymeworks Inc disclose the number of employees in R&D functions?
Does Zymeworks Inc conduct supply chain audits?
Does Zymeworks Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Zymeworks Inc conduct 360 degree staff reviews?
Does Zymeworks Inc disclose the individual responsible for D&I?
Does Zymeworks Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Zymeworks Inc disclose current and / or historical scope 2 emissions?
Does Zymeworks Inc disclose water use targets?
Does Zymeworks Inc have careers partnerships with academic institutions?
Did Zymeworks Inc have a product recall in the last two years?
Does Zymeworks Inc disclose incidents of discrimination?
Does Zymeworks Inc allow for Work Councils/Collective Agreements to be formed?
Has Zymeworks Inc issued a profit warning in the past 24 months?
Does Zymeworks Inc disclose parental leave metrics?
Does Zymeworks Inc disclose climate scenario or pathway analysis?
Does Zymeworks Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Zymeworks Inc disclose the pay ratio of women to men?
Does Zymeworks Inc support suppliers with sustainability related research and development?
Does Zymeworks Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Zymeworks Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Zymeworks Inc involved in embryonic stem cell research?
Does Zymeworks Inc disclose GHG and Air Emissions intensity?
Does Zymeworks Inc disclose its waste policy?
Does Zymeworks Inc report according to TCFD requirements?
Does Zymeworks Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Zymeworks Inc disclose energy use targets?
Does Zymeworks Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Zymeworks Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Zymeworks Inc
These potential risks are based on the size, segment and geographies of the company.
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.